Ira Duarte
CIK: 0001488864
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (30 total)
- Oct 19, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct3.9K shares- - Oct 19, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Tax Payment(F)Direct1.1K shares at avg. $0.36$396.72 - Jul 31, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Tax Payment(F)Direct3.3K shares at avg. $0.50$2K - Jul 31, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct11.7K shares- - Jul 30, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Tax Payment(F)Direct3.9K shares at avg. $0.50$2K - Jul 30, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct13.5K shares- - Jul 19, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Tax Payment(F)Direct1.1K shares at avg. $0.47$517.47 - Jul 19, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct3.9K shares- - Jun 16, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Tax Payment(F)Direct3.6K shares at avg. $0.38$1K - Jun 16, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct12.5K shares- - Apr 30, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct11.7K shares- - Apr 30, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct13.5K shares- - Apr 19, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct3.9K shares- - Jan 31, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct11.7K shares- - Jan 30, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Award(A)DirectPerformance Stock Units
216.6K shares- - Jan 30, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Award(A)DirectRestricted Stock Units
216.6K shares- - Jan 19, 2026HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct3.9K shares- - Oct 31, 2025HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct11.7K shares- - Oct 19, 2025HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct3.9K shares- - Jul 31, 2025HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct11.7K shares- - Jul 19, 2025HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct3.9K shares- - Jun 24, 2025TSNDF
TerrAscend Corp.
Award(A)Direct433.7K shares- - Jun 16, 2025HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct12.5K shares- - Apr 30, 2025HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct11.7K shares- - Apr 19, 2025HRTX
HERON THERAPEUTICS, INC. /DE/
Exercise(M)Direct3.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 19, 2026 |  HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 3,874 | - | $0 | Direct |
| Oct 19, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Tax Payment(F) | 1,102 | $0.36 | $397 | Direct |
| Jul 31, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Tax Payment(F) | 3,326 | $0.50 | $1,663 | Direct |
| Jul 31, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 11,694 | - | $0 | Direct |
| Jul 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Tax Payment(F) | 3,850 | $0.50 | $1,925 | Direct |
| Jul 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 13,535 | - | $0 | Direct |
| Jul 19, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Tax Payment(F) | 1,101 | $0.47 | $517 | Direct |
| Jul 19, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 3,874 | - | $0 | Direct |
| Jun 16, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Tax Payment(F) | 3,555 | $0.38 | $1,351 | Direct |
| Jun 16, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 12,500 | - | $0 | Direct |
| Apr 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 11,694 | - | $0 | Direct |
| Apr 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 13,535 | - | $0 | Direct |
| Apr 19, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 3,874 | - | $0 | Direct |
| Jan 31, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 11,695 | - | $0 | Direct |
| Jan 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Award(A) Performance Stock Units | 216,561 | - | - | Direct |
| Jan 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Award(A) Restricted Stock Units | 216,562 | - | - | Direct |
| Jan 19, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 3,875 | - | $0 | Direct |
| Oct 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 11,694 | - | - | Direct |
| Oct 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 3,874 | - | - | Direct |
| Jul 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 11,695 | - | - | Direct |
| Jul 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 3,874 | - | - | Direct |
| Jun 24, 2025 |  TSNDF TerrAscend Corp. | Award(A) | 433,653 | - | - | Direct |
| Jun 16, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 12,500 | - | - | Direct |
| Apr 30, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 11,694 | - | - | Direct |
| Apr 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | Exercise(M) | 3,875 | - | - | Direct |
1-25 of 30 transactions
About Duarte Ira
Duarte Ira (SEC CIK 0001488864) files insider reports with the SEC as EVP, Chief Financial Officer of HERON THERAPEUTICS, INC. /DE/ (HRTX) and Director of TerrAscend Corp. (TSNDF).
Signal8 holds 21 ownership filings by Duarte Ira, all Form 4s, filed between Oct 21, 2024 and Oct 21, 2026. Those filings report 30 transactions, from Oct 19, 2024 to Oct 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Duarte Ira's filings is in CARY, NC.
Recent filings by Duarte Ira
- Oct 19, 2026: Option exercise of HRTX shares (Form 4, code M).
- Oct 19, 2026: Tax withholding of HRTX shares (Form 4, code F).
- Jul 31, 2026: Tax withholding of HRTX shares (Form 4, code F).
- Jul 31, 2026: Option exercise of HRTX shares (Form 4, code M).
- Jul 30, 2026: Tax withholding of HRTX shares (Form 4, code F).
Other insiders filing for HERON THERAPEUTICS, INC. /DE/ (HRTX)
- Forbes William P, EVP, Chief Development Officer
- Collard Craig A, Chief Executive Officer
- Hensley Mark Earl, Chief Operating Officer
- Christian Waage, Director
- Kaseta Michael, Director
- Johnson Craig A, Director